Deregulation of the phosphoinositide-3-OH kinase (PI(3)K) pathway has been implicated in numerous pathologies including cancer, diabetes, thrombosis, rheumatoid arthritis and asthma. Recently, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback